Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP547263.RAMiaG8bX1y1_E8rJvyETXHBwnGIdUvonz8EJgd30KbmU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP547263.RAMiaG8bX1y1_E8rJvyETXHBwnGIdUvonz8EJgd30KbmU130_assertion type Assertion NP547263.RAMiaG8bX1y1_E8rJvyETXHBwnGIdUvonz8EJgd30KbmU130_head.
- NP547263.RAMiaG8bX1y1_E8rJvyETXHBwnGIdUvonz8EJgd30KbmU130_assertion description "[Monitoring breakpoint cluster region-Abelson kinase (BCR-ABL) levels in patients treated for chronic myelogenous leukemia (CML) has become an integral part of patient management.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP547263.RAMiaG8bX1y1_E8rJvyETXHBwnGIdUvonz8EJgd30KbmU130_provenance.
- NP547263.RAMiaG8bX1y1_E8rJvyETXHBwnGIdUvonz8EJgd30KbmU130_assertion evidence source_evidence_literature NP547263.RAMiaG8bX1y1_E8rJvyETXHBwnGIdUvonz8EJgd30KbmU130_provenance.
- NP547263.RAMiaG8bX1y1_E8rJvyETXHBwnGIdUvonz8EJgd30KbmU130_assertion SIO_000772 16645210 NP547263.RAMiaG8bX1y1_E8rJvyETXHBwnGIdUvonz8EJgd30KbmU130_provenance.
- NP547263.RAMiaG8bX1y1_E8rJvyETXHBwnGIdUvonz8EJgd30KbmU130_assertion wasDerivedFrom befree-2016 NP547263.RAMiaG8bX1y1_E8rJvyETXHBwnGIdUvonz8EJgd30KbmU130_provenance.
- NP547263.RAMiaG8bX1y1_E8rJvyETXHBwnGIdUvonz8EJgd30KbmU130_assertion wasGeneratedBy ECO_0000203 NP547263.RAMiaG8bX1y1_E8rJvyETXHBwnGIdUvonz8EJgd30KbmU130_provenance.